Pelthos Therapeutics Inc. is a bio-pharmaceutical company focused on commercializing FDA-approved dermatology products. Its portfolio includes ZELSUVMI (berdazimer gel, 10.3%) for molluscum contagiosum, XEPI (ozenoxacin cream, 1%) for impetigo, and XEGLYZE (abametapir) for head lice. Formed via the July 2025 merger of Channel Therapeutics Corporation and LNHC, Inc., the company also holds clinical-stage assets targeting the NaV1.7 sodium ion-channel for pain and maintains a manufacturing facility for its NITRICIL technology platform.
Q2 FY2026 — expected 2026-09-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-19 | 2025-12-31 | 0001919246-26-000013 | EDGAR | 113K words |
| 2025-03-27 | 2024-12-31 | 0001753926-25-000503 | EDGAR | 95K words |
| 2024-04-16 | 2023-12-31 | 0001753926-24-000740 | EDGAR | 93K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-13 | 2026-06-30 | 0001919246-26-000113 | EDGAR | 45K words |
| 2025-11-13 | 2025-09-30 | 0001753926-25-001764 | EDGAR | 51K words |
| 2025-08-13 | 2025-06-30 | 0001753926-25-001326 | EDGAR | 33K words |
| 2025-05-13 | 2025-03-31 | 0001753926-25-000790 | EDGAR | 27K words |
| 2024-11-13 | 2024-09-30 | 0001753926-24-001883 | EDGAR | 28K words |
| 2024-08-13 | 2024-06-30 | 0001753926-24-001423 | EDGAR | 25K words |
| 2024-05-15 | 2024-03-31 | 0001753926-24-000976 | EDGAR | 22K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-13 | 0001919246-26-000112 | EDGAR | 4K words |
| 2026-08-13 | 0001919246-26-000110 | EDGAR | 1K words |
| 2026-03-19 | 0001919246-26-000014 | EDGAR | 4K words |
| 2026-01-13 | 0001753926-26-000097 | EDGAR | 1K words |
| 2026-01-12 | 0001753926-26-000094 | EDGAR | 3K words |
| 2026-01-02 | 0001753926-26-000010 | EDGAR | 1K words |
| 2025-12-23 | 0001753926-25-001964 | EDGAR | 1K words |
| 2025-12-17 | 0001753926-25-001906 | EDGAR | 1K words |
| 2025-11-13 | 0001753926-25-001766 | EDGAR | 3K words |
| 2025-11-07 | 0001753926-25-001715 | EDGAR | 2K words |
59 total filings indexed. 39 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001919246 |
| Ticker | PTHS |
| Exchange | NYSE |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | NV |
| Website | https://www.pelthos.com |
| Listed | 2024-02-16 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/PTHS (~200 tokens, structured JSON with cryptographic provenance)